Aehr Test Systems Reinstates Guidance, Projects Strong H2 FY26 Bookings Driven by AI and Diversification
Summary
Aehr Test Systems reported a weaker Q2 fiscal 2026 but reinstated guidance, projecting strong bookings of $60M-$80M for H2 FY26, driven by AI and market diversification.
Key Events
-
Q2 Fiscal 2026 Financial Results
Net revenue was $9.9 million, down from $13.5 million in Q2 FY25. GAAP net loss was $(3.2) million, or $(0.11) per diluted share, compared to a loss of $(1.0) million in the prior year. Non-GAAP net loss was $(1.3) million, or $(0.04) per diluted share, compared to non-GAAP net income of $0.7 million in Q2 FY25. Bookings for the quarter were $6.2 million.
-
Guidance Reinstatement and Strong Future Outlook
The company reinstated guidance for the second half of fiscal 2026, expecting revenue between $25 million and $30 million and a non-GAAP net loss per diluted share between $(0.09) and $(0.05). Management projects bookings between $60 million and $80 million for H2 FY26, signaling a very strong fiscal 2027.
-
AI and Market Diversification Driving Growth
Aehr is seeing significant momentum in AI processors, with a lead customer requesting additional capacity and new custom high-power WaferPaks in testing. The company announced a strategic partnership with ISE Labs for advanced wafer-level test and burn-in services and received over $5.5 million in orders for its Sonoma ultra-high-power PPBI systems in Q3 to date. Aehr is also expanding into silicon photonics and flash memory, diversifying its customer base beyond its previous concentration in silicon carbide for electric vehicles.
Analysis
Aehr Test Systems reported a softer-than-anticipated second quarter, with revenue and net income declining year-over-year. However, the company reinstated its financial guidance for the second half of fiscal 2026, projecting significant bookings between $60 million and $80 million. This outlook is driven by improved visibility in AI processor and data center semiconductor test and burn-in systems, alongside strategic diversification into new markets like silicon photonics and flash memory. The substantial projected bookings for the second half of the fiscal year, which are many times the reported quarterly revenue, indicate a strong anticipated rebound and future growth, setting a positive stage for fiscal 2027. Investors should monitor the realization of these bookings and the continued expansion into new high-growth markets.
At the time of this filing, AEHR was trading at $21.10 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $681.1M. The 52-week trading range was $6.27 to $34.35. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.